BRI3BP Polyclonal Antibody, Cy5.5 Conjugated
Product Specifications
Background
Involved in tumorigenesis and may function by stabilizing p53/TP53.
Synonyms
KG19; BNAS1; HCCR-1; HCCR-2; HCCRBP-1; BRI3-binding protein; I3-binding protein; Cervical cancer 1 proto-oncogene-binding protein KG19; BRI3BP
Gene ID
140707
Swiss Prot
Q8WY22
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
188-251/251
Target
BRI3BP
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human BRI3BP
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
140707
Predicted Cross Reactivity
Mouse, Rat, Dog, Cow, Chicken
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD45 / LCA (2B11 + PD7/26), CF647 conjugate, 0.1mg/mL
CD59 (heavy chain of Protectin) (BRA-10G), CF640R conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF740 conjugate, 0.1mg/mL
Cytokeratin, LMW (AE-1), CF405S conjugate, 0.1mg/mL
